Clinically formulated fat-reduction solution containing 3000GDU/g bromelain and 98% pure lecithin. Proven to reduce adipocyte size by 23%* in clinical observations while improving skin elasticity through enhanced collagen synthesis. FDA-registered facility manufactured by Maypharm Co., Ltd (Korea).

Patented Delivery System:
• 30G microcannula-compatible formula
• 0.2-0.5ml/cm² tissue saturation
• pH-balanced (6.8-7.2) for minimal irritation

Application Protocol:
1. Administer 2-3ml per facial zone
2. 1cm grid pattern injection
3. Post-treatment lymphatic massage
4. 14-day treatment intervals
⚠ Maximum 8ml per session

*Clinical data from 2023 Maypharm trials. For licensed practitioners only. Not for pregnancy/nursing patients. Store at 15-25°C. Results may vary based on metabolic factors and treatment adherence.